跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EV-200
首页
药物
EV-200
EV-200
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
SAFE AND STABLE EDIBLE MATERIAL HAVING REINFORCED CONCRETE-LIKE STRUCTURE
US 2008213412 A1
申请人: YAMADA YASUYUKI
优先权: 2005
US
Effective constituent capable of resisting intestinal EV-71 virus in grubs and preparing method thereof
CN 106109501 A
申请人: ZHOU ZHANGZHENG
优先权: 2016
CN
Effective part capable of resisting enteric EV-71 virus in fortune eupatorium herb and preparation method
CN 106668108 A
申请人: ZHOU CHANGZHENG
优先权: 2017
CN
具有降尿酸功效的牡蛎多肽、多肽粉及制备方法和应用
CN 114032271 B
申请人: 浙江工业大学
优先权: 2021
CN
Extracellular vesicle drug delivery system as well as preparation method and application thereof
CN 117379557 A
申请人: SHANXI BETHUNE HOSPITAL SHANXI HOSPITAL OF MEDICAL SCIENCES SHANXI HOSPITAL OF HUAZHONG UNIV OF MEDI
优先权: 2023
CN
High-efficiency thermally activated delayed fluorescent material based on phenyl-pyrimidine-triphenylamine and application of high-efficiency thermally activated delayed fluorescent material in organic light-emitting diode
CN 120717956 A
申请人: UNIV DALIAN TECH
优先权: 2025
CN
PH-responsive bismuth-based nano-drug, and preparation method and pharmaceutical application thereof
CN 122097580 A
申请人: UNIV SHANGHAI SCIENCE & TECH
优先权: 2026
CN
药物
反馈